16:01 EST Contineum (CTNM) Therapeutics Inc trading halted, news pending
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTNM:
- Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities
- Contineum Therapeutics Reports Increased R&D Investment Amid Losses
- Contineum reports Q3 EPS (45c), consensus (46c)
- Buy Rating for Contineum Therapeutics Driven by Strategic Positioning and Enhanced Efficacy in IPF Market
- Leerink bullish on Contineum, initiates with an Outperform